EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ryman Healthcare's EBITDA for the
six
months ended in Mar. 2025 was $-160.7 Mil. Ryman Healthcare's Revenue for the
six
months ended in Mar. 2025 was $212.5 Mil. Therefore, Ryman Healthcare's EBITDA margin for the quarter that ended in Mar. 2025 was -75.63%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ryman Healthcare EBITDA Margin % Related Terms
Ryman Healthcare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Ryman Healthcare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RYHTY vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Ryman Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ryman Healthcare EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ryman Healthcare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ryman Healthcare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ryman Healthcare (RYHTY) has a EBITDA Margin % of -75.63% as of Mar. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ryman Healthcare and its competitors. According to the industry distribution chart, Ryman Healthcare ranks #516 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 77.2%.
Is Ryman Healthcare's EBITDA Margin % too high?
Ryman Healthcare's current EBITDA Margin % is -75.63%. Based on the distribution chart, Ryman Healthcare ranks #516 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ryman Healthcare has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Ryman Healthcare's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ryman Healthcare ranks #516 out of 668 companies for EBITDA Margin %. This places Ryman Healthcare in the lower half of its industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ryman Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ryman Healthcare's current EBITDA Margin % is -75.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ryman Healthcare stock overvalued right now?
Ryman Healthcare (RYHTY) has a current EBITDA Margin % of -75.63%. The stock's GF Value™ is $17.68, compared to a current price of $6.11 — trading 65.4% below its estimated fair value. The current EBITDA Margin % is -75.63%. Ryman Healthcare's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ryman Healthcare (RYHTY), the current EBITDA Margin % is -75.63% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ryman Healthcare (RYHTY) Overvalued in 2026?
Based on GuruFocus' analysis, Ryman Healthcare stock appears to be undervalued.
The current stock price of $6.11 is trading 65.4% below its estimated GF Value™ of $17.68.
Key valuation signals for RYHTY:
EBITDA Margin %: -75.63%
GF Value™: $17.68 vs. price of $6.11 (65.4% below fair value)
No single metric tells the full story. See the RYHTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ryman Healthcare Ltd is a retirement living and aged care provider operating in New Zealand and Australia. It owns and operates integrated retirement villages through its trading subsidiaries, which operate in the aged care and retirement living sector in New Zealand and Australia. The Group operates in a single industry: the provision of integrated retirement living and aged care for older people in New Zealand and Australia. The majority of revenue is derived from Care and village fees, which relate to the provision of accommodation, care and related services to aged care residents and retirement living residents.
70GF Score
Get the complete analysis for RYHTY
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYHTY has been successfully added to your 
